Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Q4 FY2025-26 Earnings Presentation
29 slides from Privi Speciality Chemicals's earnings presentation, May 11, 2026
Slide 1: Letter to BSE and NSE on Investor Presentation
4, May Ll,2O26 The Manager (CRD) The Manager - Listing Department The BSE Limited NationalStock Exchange of tndia Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no.Cf!, G Block, Dalal Street Fort, Bandra-Kurla Complex, Bandra (East) Mumbai- 400001 Mumbai - 400 051 Scrip Code: 530117 Symbol: PRI
Slide 2: Investor Presentation Q4 and FY25-26
Investor Presentation Q4 and FY25-26 PRIVI SPECIALITY CHEMICALS LIMITED We d o d i ffe re nt t hi ng s, We d o t hi ng s d i ffe re nt l y Prosperity With Orderliness
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Privi Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe fo
Slide 4: Index
Index 01 02 Chairman's Message Q4 & FY26 Results Strategic vision and performance overview Consolidated performance metrics 03 04 Company Overview Growth Strategy About Us Strategic priorities and outlook 05 Sustainability Prosperity With Orderliness
Slide 5: From the CMD's Desk
From the CMD’s Desk Over the past few years, we have reshaped Privi into a more resilient and diversified organization, supported by a broad product range, strong customer partnerships, and an expanding global presence. This has strengthened our ability to deliver consistent performance and navigate
Slide 6: Performance at a glance
Performance at a glance Q4 FY25-26 Revenue EBITDA EBITDA Margin PAT Rs. 725.70 Cr. Rs. 184.41 Crs 25.4 % Rs. 93.7 Cr. 15.5% YoY 25.1% YoY 195 bps 40.9% YoY FY25-26 Revenue EBITDA EBITDA Margin PAT Rs. 2,582.92 Cr. Rs. 665.45 Cr. 25.8 % Rs. 327.54 Cr. 21.7% YoY 40.3% YoY 342 bps 75.2% YoY ROCE ROE Ne
Slide 7: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars (Rs. Cr.) Q4FY26 Q4FY25 YoY FY26 FY25 YoY Revenue from operations 721.52 613.55 2,563.69 2,101.19 Other income 4.18 14.82 19.24 20.65 Total income 725.70 628.37 15.5% 2,582.92 2,121.84 21.7% Raw Material 405.62 340.49 1,317.10 1,131.49 Power and fuel 45
Slide 8: Consolidated Balance Sheet
Consolidated Balance Sheet Assets (Rs Cr.) FY26 FY25 Liabilities (Rs Cr.) FY26 FY25 Non Current Assets Equity Property, Plant and Equipment 1,111.68 1,097.89 Equity Share capital 39.06 39.06 Capital work-in-progress 297.65 127.47 Other Equity 1,373.37 1,064.37 Intangible assets 7.44 10.64 Non Contro
Slide 9: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs. Cr.) FY26 FY25 Net Profit Before Tax 439.70 254.52 Adjustments for: Non Cash Items / Other Investment or Financial Items 236.03 235.81 Operating profit before working capital changes 675.74 490.33 Changes in working capital -9.31 -138.56 Cash generat
Slide 10: Steady Growth in Annual Performance
Steady Growth in Annual Performance Total Income (Rs. In Cr) EBITDA (Rs. In Cr) EBITDA Margin (%) PAT (Rs. In Cr) / Margin (%) 1.31% 5.37% 8.81% 12.68% +17% 2,582.92 2,121.84 25.76% 1,778.53 +48% 665.45 1,629.24 22.35% 327.54 474.16 19.95% +149% 187.00 354.82 12.73% 207.34 95.43 21.28 FY23 FY24 FY25
Slide 11: Company Overview
COMPANY OVERVIEW PRIVI SPECIALITY CHEMICALS LIMITED Prosperity With Orderliness
Slide 12: India's Leading Aroma Chemicals Manufacturer
Leading manufacturer, Supplier & Exporter of Aroma Chemicals India's Leading Aroma Chemicals Manufacturer A 30+ year track record of building global leadership in pine- based and speciality aroma chemicals — supplying the world's top fragrance and FMCG companies. 75+ 48,000 MTPA 2 R&D CENTRES 7 40+
Slide 13: Our Journey
Our Journey 2023 2025 2026 Way Forward Crossed turnover of Rs 1,500 Crores Turnover crossed Rs. 2,000 Crores. Turnover crossed Rs. 2,500 Crores. Working on 5K:1K plan Launched Galaxmusk, Camphor and Comissioned and commenced Prionyl. commercial production at PRIGIV 2021 2020 2019 2017 Promoter bough
Slide 14: Geographical Presence
Geographical Presence Manchester Rotterdam Milano Grasse New Jersey Mahad, Maharastra Jhagadia, Gujarat India Shanghai Mexico Singapore 2 Manufacturing 7 Distribution 3 Stocking Serving 40+ Sites Centres Points Countries Disclaimer: This map is a generalised illustration only for the ease of the rea
Slide 15: Competitive Advantages
Competitive Advantages Robust Manufacturing • Privi’s state-of-the-art manufacturing capacities are amongst the largest globally • Manufacturing infrastructure has the best-in-class regulatory compliance & certifications Backward Integration • Integrated inhouse developed CST processing for manufact
Slide 16: PRIGIV — Strategic JV with Givaudan
PRIGIV — Strategic JV with Givaudan PRIGIV Plant at Mahad, MH 51% 49% India's leading manufacturer of aroma Swiss multinational manufacturer of flavours, and fragrance chemicals fragrances and active cosmetic ingredients Globally trusted partner and a preferred World's largest company in the flavour
Slide 17: High R&D focus to develop new products and processes
High R&D focus to develop new products and processes R&D team strength 02 R&D Centers at 114 including scientist, microbiologist & chemistry Mahad and Nerul professionals Synthetic Organic Research lab and Pilot plants are approved by the Department of Scientific and New Product Development Industri
Slide 18: Operational Excellence: Driving Efficiency, Quality & Sustainability
Operational Excellence : Driving Efficiency, Quality & Sustainability Safety & People Sustainability R&D & Quality Process Efficiency Asset & Capacity • Regular safety audits • About 70% raw materials • 2 R&D centers (Mahad & Nerul) • Continuous process • Capacity debottlenecking and emergency drill
Slide 19: Growth Strategy
GROWTH STRATEGY PRIVI SPECIALITY CHEMICALS LIMITED Prosperity With Orderliness
Slide 20: Marching towards Vision – 5k | 1k Milestone
Marching towards Vision – 5k | 1k Milestone* New Projects and Products On track to achieve the vision of Rs 5,000 Cr revenue and Rs 1,000 Cr + EBITDA by FY29-30, representing more • Existing products expansion than 2x growth. • Maltol and Ethyl Maltol • Renewable Cyclopentanone • 10+ other High end
Slide 21: Proposed Scheme of Amalgamation
Proposed Scheme of Amalgamation Privi Fine Sciences Private Limited (PFSPL) + Privi Biotechnologies Private Limited (PBPL) + Privi Speciality Chemicals Limited (PSCL) Key Rationale Diverse Product Portfolio Green Science Advantage PFSPL includes Privial, Anethole, and Cyclamen Aldehyde used in fine
Slide 22: Key Growth Levers
Key Growth Levers Existing Product Expansion Expanding the reach of current products China +1 Strategy to increase sales Diversifying supply chains with a focus on China and additional 1 markets 6 New Product Innovation 2 Introducing new products, in synergy with existing raw material Incentive Grow
Slide 23: Key Business Highlights 5k:1k and beyond
Key Business Highlights 5k:1k and beyond Expansion Intellectual Capacity Information Biorefinery In-house talent Projects Property Augmentation Technology Speciality molecule Significant progress in Technology group Privi harnessing in- Flagship product Strengthening its expansion projects scaling b
Slide 24: Demand Outlook: Trends and Features
Demand Outlook : Trends and Features Privi is well positioned to meet the rising demand of aroma chemicals with strong competitive advantages Increasing Awareness and Growing End-use Segments to Drive Demand Global Aroma Chemicals Market Size Growing Urbanization and Lifestyle Upgrade Shift towards
Slide 25: Sustainability
Sustainability PRIVI SPECIALITY CHEMICALS LIMITED Prosperity With Orderliness
Slide 26: Privi's Sustainability Journey – From Bronze to Platinum
Privi’s Sustainability Journey – From Bronze to Platinum Highest possible certification provided by Ecovadis - World’s most trusted sustainability rating Top 1% globally in Environment, Recognized for Validated by International Aligned with Global Labor, Ethics & Sustainable Responsible chemical Cli
Slide 27: Sustaining Growth with Responsibility
Sustaining Growth with Responsibility Climate - Scope 1 and 2 Reduction of 50.4 % by 2032 comparing base year of 2022 - 35 % reduction of Scope 3 GHG emissions by 2034 comparing base year of 2024 - To perform Product Carbon footprint for 20 products contributing 70% of revenue Energy Source 50% ener
Slide 28: Core Values – 5S
Core Values – 5S Key Recognitions Embedded across Safety manufacturing and R&D functions Reflected in Sustainability financial management and product development Applied to market Sense of opportunities and Urgency strategic joint ventures Key Certifications Evident in Super stakeholder Transparency
Slide 29: Thank You
Thank You For further queries, Please contact: Company : Mr. Sanjeev Patil Executive Vice President - Strategy investors@privi.co.in www.privi.co.in Investor Relations Advisors : Adfactors PR Pvt. Ltd. Rushabh Shah: rushabh.shah@adfactorspr.com M: +91 8082180182 Pratik Shah: pratik.shah@adfactorspr.
Privi Speciality Chemicals — Q4 FY2025-26 Earnings Presentation on 6ix